Clinical Trial Update: Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating stopping tyrosine kinase inhibitors in patients with chronic myeloid leukemia who have a stable molecular response, in a real-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: Baylor College of Medicine | Conditions: Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission | Phase 2 | Status: RECRUITING